期刊文献+

Smad4反义寡核苷酸对高糖培养的人肾小球系膜细胞分泌纤连蛋白、层黏连蛋白的影响

Influence of Smad4 antioligodeoxynucleotide on fibronectin and laminin excretion by human glomerular mesangial cells under hyperglycemia
下载PDF
导出
摘要 目的观察Smad4反义寡核苷酸(antioligodeoxynucleotide,antiODN)对体外高糖培养的人肾小球系膜细胞(human glomerular mesangial cells,HGMC)分泌纤连蛋白(fibronectin,FN),层黏连蛋白(laminin,LN)的影响。方法用脂质体法将正义、反义、错义Smad4寡核苷酸瞬时转染体外培养的HGMC,并进行高糖培养,同时设立正常糖组、高糖组、甘露醇组、脂质体组为对照组,用ELISA法检测培养上清液中FN、LN的含量,进行统计学分析。结果转染Smad4反义寡核苷酸的HGMC分泌的FN、LN量与正常对照组相比无统计学意义(P>0.05),而与高糖组、正义组、错义组相比差异有统计学意义(P<0.01)。结论随着高糖作用的时间延长,体外培养的HGMC分泌的FN、LN量逐渐增加,而转染Smad4 antiODN可以抑制高糖的刺激,减少FN、LN的表达,从而减少系膜细胞细胞外基质的堆积,为延缓肾脏纤维化提供了新的途径。 [Objective] To observe the effects of Smad4 antioligodeoxynucleotide (antiODN) on the excretion of fibroneefin (FN) and lanfinin (LN) by human glomerular mesangial ceils (HGMC) under hyperglycemia. [Methods] Anfisense, sense and misssense Smad40DNs were transferred transiently into human glomerular mesangial cells with liposome. HGMCs were cultured with high glucose and normal glucose, high glucose, mannitol and lipofectamine 2000 were used as control. The secretion of fibronecfin and laminin by HGMCs in supernatants of culture media was evaluated by ELISA. [Results] Compared with high glucose, antisense and missense groups, concentrations of FN and LN decreased significantly in antisense group (P 〈0.05), the value nearly approach the normal (.P 〉 0.05). [ Conclusion] FN and LN secreted by HGMC cultured under high-glucose conditions were increased in a time-dependent manner. Antisense Smad40DN can reduce the FN and LN secretion in HGMC cultured with high glucose.The study supply a new method of diabetic nephropathy.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2011年第1期10-13,18,共5页 China Journal of Modern Medicine
基金 辽宁省自然基金(No:20032068) 辽宁省教育厅科学技术基金(No:202013140)
关键词 SMAD4 寡核苷酸 纤连蛋白 层黏连蛋白 smad4 oligodeoxynudeotides fibroneetin laminin
  • 相关文献

参考文献11

  • 1MARY H BB, JEFFREY. TGF-β and fibrosis [J]. Microbes and Infection, 1999, 1(15): 1349-1365.
  • 2MARTA RO, JUAN R, ELSA SL, et al. TGF-β signaling in vascular fibrosis [J]. Cardiovascular Research, 2007, 74 (2): 196-206.
  • 3WANG W, KOKA V, LAN HY. Transfoming growth factor-beta and Smad signalling in kidney disease [J]. Nephrology (Carlton), 2005, 10(1): 48-56.
  • 4NADIA ABDEL WAHAB, BENJAMIN S, WESTON and ROGER M. MASON. Modulation of the TGF-β/Smad signaling pathway in mesangial cells by CTGF/CCN2 [J]. Experimental Cell Research, 2005, 307(2): 305-314.
  • 5BAI S, CAO X. A nuclear antagonistic mechanism of inhibitory Smads in transforming growth factor-beta signaling[J]. Bial Chem, 2002, 274(47): 33412-33418.
  • 6SUNIL K. HALDER R. Daniel Beanchamp and Pran K. Datta. Smad7 induces tumorigenicity by blocking TGF-β-induced growth inhibition and apoptosis [J]. Experimental Cell Research, 2005, 307(1): 231-246.
  • 7MAGDALENA D, MALGORZATA D, ALEKSANDRA W, et al.Cross-talk between Smad and p38 MAPK signalling in trans- forming growth factor β signal transduction in human glioblastoma cells[J]. Biochemical and Boiphysical Research Communications, 2007, 354(4): 1101-1106.
  • 8SHI Y, MASSAGUE J. Mechanisms of TGF-β signaling from cell membrane to the nucleus[J]. Cell, 2003, 113(6): 685.
  • 9QIN B, LAM SS, LIN K. Crystal structure of a transcriptionally active Smad4 fragment[J]. Structure Fold Des, 1999, 7(12): 1493.
  • 10WEI HE, DAVID C DORN, HEDIYE ERDJUMENT-BRO- MAGE, et al. Hematopoiesis Controlled by Distinct TIF1 γ and Smad4 Branches of the TGFβ Pathway [J]. Cell 2006, 125(5): 929-941.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部